The Sun
UK · 1 hrs ago
✦ 72◉ Centre
Immune-boosting jab shrinks cancer in nearly half of incurable patients
72Quality
0Ratings
0Comments
AI Analysis
Quality 72/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ⚠ Misleading headline
A trial has found that amivantamab, an immunotherapy injection available on the NHS, shows promise in shrinking tumours in patients with advanced cancer who have exhausted other treatment options.
Immune-boosting jab shrinks cancer in nearly half of incurable patients
A CANCER jab available on the NHS can melt away tumours when patients have run out of options, a trial found. Triple-action injection amivantamab works by blocking a growth protein and an enzyme that makes tumours immune-resistant, as well as boosting white blood cells to help them kill the cancer. A study of 102 people...
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!